137 related articles for article (PubMed ID: 24368216)
21. Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity.
Jing Y; Ma R; Chu Y; Dou M; Wang M; Li X; Zhu L
J Chem Neuroanat; 2021 Nov; 117():102004. PubMed ID: 34280490
[TBL] [Abstract][Full Text] [Related]
22. Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy.
Wang MR; Zhang XJ; Liu HC; Ma WD; Zhang ML; Zhang Y; Li X; Dou MM; Jing YL; Chu YJ; Zhu L
Brain Res Bull; 2019 Nov; 153():30-38. PubMed ID: 31404585
[TBL] [Abstract][Full Text] [Related]
23. Matrine treatment reduces retinal ganglion cell apoptosis in experimental optic neuritis.
Kang J; Liu S; Song Y; Chu Y; Wang M; Shi Y; Zhang F; Zhu L
Sci Rep; 2021 May; 11(1):9520. PubMed ID: 33947942
[TBL] [Abstract][Full Text] [Related]
24. Blocking glutamate carboxypeptidase II inhibits glutamate excitotoxicity and regulates immune responses in experimental autoimmune encephalomyelitis.
Ha D; Bing SJ; Ahn G; Kim J; Cho J; Kim A; Herath KH; Yu HS; Jo SA; Cho IH; Jee Y
FEBS J; 2016 Sep; 283(18):3438-56. PubMed ID: 27444540
[TBL] [Abstract][Full Text] [Related]
25. Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS.
Dou M; Zhou X; Li L; Zhang M; Wang W; Wang M; Jing Y; Ma R; Zhao J; Zhu L
Front Immunol; 2021; 12():640778. PubMed ID: 33912166
[TBL] [Abstract][Full Text] [Related]
26. Antiepileptic potential of matrine via regulation the levels of gamma-aminobutyric acid and glutamic acid in the brain.
Xiang J; Jiang Y
Int J Mol Sci; 2013 Dec; 14(12):23751-61. PubMed ID: 24317434
[TBL] [Abstract][Full Text] [Related]
27. Prophylactic versus Therapeutic Fingolimod: Restoration of Presynaptic Defects in Mice Suffering from Experimental Autoimmune Encephalomyelitis.
Bonfiglio T; Olivero G; Merega E; Di Prisco S; Padolecchia C; Grilli M; Milanese M; Di Cesare Mannelli L; Ghelardini C; Bonanno G; Marchi M; Pittaluga A
PLoS One; 2017; 12(1):e0170825. PubMed ID: 28125677
[TBL] [Abstract][Full Text] [Related]
28. N-Methyl-D-aspartate (NMDA) receptor involvement in central nervous system prostaglandin production during the relapse phase of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).
Bolton C; Wood EG; Ayoub SS
Fundam Clin Pharmacol; 2013 Oct; 27(5):535-43. PubMed ID: 22742874
[TBL] [Abstract][Full Text] [Related]
29. Ndrg2 deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis.
Le TM; Takarada-Iemata M; Ta HM; Roboon J; Ishii H; Tamatani T; Kitao Y; Hattori T; Hori O
J Neurochem; 2018 Apr; 145(2):139-153. PubMed ID: 29315585
[TBL] [Abstract][Full Text] [Related]
30. Participation of the GABAergic system on the glutamate release of frontal cortex synaptosomes from Wistar rats with experimental autoimmune encephalomyelitis.
Cid MP; Vilcaes AA; Rupil LL; Salvatierra NA; Roth GA
Neuroscience; 2011 Aug; 189():337-44. PubMed ID: 21635939
[TBL] [Abstract][Full Text] [Related]
31. Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis.
Sulkowski G; Dąbrowska-Bouta B; Chalimoniuk M; Strużyńska L
J Neuroimmunol; 2013 Aug; 261(1-2):67-76. PubMed ID: 23746391
[TBL] [Abstract][Full Text] [Related]
32. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics.
Pajarillo E; Rizor A; Lee J; Aschner M; Lee E
Neuropharmacology; 2019 Dec; 161():107559. PubMed ID: 30851309
[TBL] [Abstract][Full Text] [Related]
33. Glutamate, T cells and multiple sclerosis.
Levite M
J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
[TBL] [Abstract][Full Text] [Related]
34. Roles of the NMDA Receptor and EAAC1 Transporter in the Modulation of Extracellular Glutamate by Low and High Affinity AMPA Receptors in the Cerebellum in Vivo: Differential Alteration in Chronic Hyperammonemia.
Cabrera-Pastor A; Taoro L; Llansola M; Felipo V
ACS Chem Neurosci; 2015 Dec; 6(12):1913-21. PubMed ID: 26428532
[TBL] [Abstract][Full Text] [Related]
35. Primary cultures of rat cortical microglia treated with nicotine increases in the expression of excitatory amino acid transporter 1 (GLAST) via the activation of the α7 nicotinic acetylcholine receptor.
Morioka N; Tokuhara M; Nakamura Y; Idenoshita Y; Harano S; Zhang FF; Hisaoka-Nakashima K; Nakata Y
Neuroscience; 2014 Jan; 258():374-84. PubMed ID: 24300109
[TBL] [Abstract][Full Text] [Related]
36. Suppressive effects of intrathecal granulocyte colony-stimulating factor on excessive release of excitatory amino acids in the spinal cerebrospinal fluid of rats with cord ischemia: role of glutamate transporters.
Chen WF; Sung CS; Jean YH; Su TM; Wang HC; Ho JT; Huang SY; Lin CS; Wen ZH
Neuroscience; 2010 Feb; 165(4):1217-32. PubMed ID: 19932886
[TBL] [Abstract][Full Text] [Related]
37. Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Grasselli G; Rossi S; Musella A; Gentile A; Loizzo S; Muzio L; Di Sanza C; Errico F; Musumeci G; Haji N; Fresegna D; Sepman H; De Chiara V; Furlan R; Martino G; Usiello A; Mandolesi G; Centonze D
Br J Pharmacol; 2013 Jan; 168(2):502-17. PubMed ID: 22924679
[TBL] [Abstract][Full Text] [Related]
38. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
[TBL] [Abstract][Full Text] [Related]
39. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
[TBL] [Abstract][Full Text] [Related]
40. The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1.
Razafimanjato H; Garmy N; Guo XJ; Varini K; Di Scala C; Di Pasquale E; Taïeb N; Maresca M
Neurotoxicology; 2010 Sep; 31(5):475-84. PubMed ID: 20558201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]